Supplement brand Rainbow Light has come to a $1.75 million settlement with Los Angeles City Attorney Mike Feuer over claims the company was making about lead levels in its products.
Facilities that are subject to FSMA inspections are struggling with the initial implementation of the Foreign Supplier Verification Provision of the law, new data shows. The issue is coming to a head with the first warning letter based on a FSVP failure.
The rollout of New Age Beverages’ CBD-infused beverages has been delayed owing to the regulatory uncertainty over CBD, which makes navigating the territory “as murky as the Strait of Hormuz,” CEO Brent Willis told analysts yesterday.
A key element of the CBD debate will be determining best practices of when and how to measure the THC content of products, said an expert with long experience in the botanicals field.
The European Food Safety Authority (EFSA) confirms nicotinamide riboside (NR) chloride’s safety in its latest scientific opinion, additionally vouching for this Novel Food’s (NF) profile as a reliable niacin (vitamin B3) source.
Trade body Complementary Medicines Australia (CMA) has reassured the safety of Australian made supplements but cautioned against the online purchase of overseas products, amid ongoing doping saga involving national swimmer Shayna Jack.
The European Food and Safety Authority (EFSA) are unable to establish an agreed dose, in which consumers can safely consume the embryonated eggs of a whipworm as a food supplement.
An unfair trade case has been filed before the International Trade Commission over beta hydroxybutyrate (BHB), a popular ingredient in sports nutrition and weight management.
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
The Danish Food Agency is to increase the amount of iodine in salt in a move that looks to address a deficiency in pregnant and breastfeeding women as well as in the country’s general population.
In an editorial published yesterday former FDA Commissioner Scott Gottlieb said the agency needs to act quickly on CBD, but must not compromise on its mission of safety in doing so.
Italy’s National Institute of Health reports a number of products currently available on the Italian market that consumers should avoid due to the detection of erectile dysfunction drugs.
Italy’s National Institute of Health concludes that the hepatitis cases linked to the consumption of curcumin-containing supplements was due to “individual susceptibility” or “pre-existing alterations.”
